The first quarter of 2025 witnessed a wave of major mergers and acquisitions (M&A) across industries, signaling a dynamic shift in multiple sectors—from tech and energy to healthcare and finance. Q1 saw deal values soaring into billions, with companies positioning themselves for strategic advantage, expansion, and innovation. Tech sector M&A led the quarter, with some of the largest deals driven by the race in artificial intelligence and cloud computing. Let us look at some of the most significant m&A deals in this year’s first quarter (January – March).

Tech Majors Make Bold Moves
xAI Acquires X for $33 Billion
In a surprise move, Elon Musk merged his social media and AI ventures. His AI startup xAI acquired the X platform (formerly Twitter) in an all-stock deal valuing X at $33 billion. Musk framed this unusual transaction as a way to “combine the data, models, compute, distribution and talent” of the social network with xAI’s AI development. The move will help xAI train its Grok chatbot on X’s vast real-time social data. Musk said the combination values “xAI at $80 billion and X at $33 billion ($45B less $12B debt)”. So far, this is currently the largest deal of 2025.
Alphabet Inc. Acquires Wiz for $32 Billion
Google’s parent company, Alphabet Inc., has acquired cloud security startup Wiz for $32 billion, one of the largest acquisitions in Google’s history. Wiz provides security solutions across major cloud environments, including Amazon Web Services, Microsoft Azure, and Google Cloud Platform. This acquisition will enhance Google’s cloud security offerings by addressing the growing demand for robust cybersecurity solutions in multi-cloud and hybrid environments. Integrating Wiz’s security solutions will help customers improve security, reduce costs, and accelerate the adoption of cloud computing.
Strategic Plays in Infrastructure and Energy
BlackRock-TiL Consortium Takes Over Panama Canal Ports
A consortium led by BlackRock and Terminal Investment Limited (TiL) plans to acquire a significant portion of CK Hutchison Holdings’ port operations. The deal, valued at approximately $22.8 billion, also includes 43 ports across 23 countries and a 90% stake in the Panama Ports Company (PPC), which manages the Balboa and Cristobal terminals at the Panama Canal.
This acquisition follows concerns raised by U.S. President Donald Trump regarding Chinese influence over strategic assets near the Panama Canal. The transaction will shift control of these critical ports from Hong Kong-based CK Hutchison to the U.S.-led consortium. Chinese authorities have initiated an antitrust review, delaying the finalization of the sale.
Constellation Energy Buys Calpine for $16.4 Billion
The energy sector saw major consolidation with Constellation Energy Corporation’s acquisition of Calpine for $16.4 billion. The deal will create the largest clean energy provider in the United States, combining Constellation’s extensive nuclear power portfolio with Calpine’s significant natural gas and geothermal assets.
The deal is expected to close within 12 months, pending regulatory approvals from agencies, including the Federal Energy Regulatory Commission and the Public Utility Commission of Texas.
Healthcare & Pharma Go Big
Johnson & Johnson Acquires Intra-Cellular Therapies
In January 2025, Johnson & Johnson announced its agreement to acquire Intra-Cellular Therapies, a biopharmaceutical company specializing in central nervous system disorder treatments, for approximately $14.6 billion. The acquisition was completed on April 2, 2025. The acquisition will strengthen J&J’s neuroscience and mental health drug pipeline, an area gaining renewed attention post-pandemic.
The deal will add CAPLYTA® (lumateperone), a once-daily oral therapy approved for treating adults with schizophrenia and depressive episodes associated with bipolar I or II disorder, to Johnson & Johnson’s portfolio. Intra-Cellular Therapies has also submitted a supplemental new drug application for CAPLYTA® as an adjunctive treatment for major depressive disorder.
Mallinckrodt Merges with Endo Pharmaceuticals
On March 13, 2025, Mallinckrodt Pharmaceuticals and Endo Pharmaceuticals merged in a $6.7 billion deal. The merger will create a diversified pharmaceutical company with a significant presence in the United States and internationally. It will also help leverage the complementary strengths of both companies, combining their portfolios of branded and generic pharmaceuticals, as well as sterile injectables.
The merged company will operate 17 manufacturing facilities and 30 distribution centers upon completion. This expanded infrastructure is expected to enhance the company’s ability to serve patients and healthcare providers across various therapeutic areas.
Building & Construction Consolidation
QXO Inc Acquires Beacon Roofing Supply for $11 Billion
QXO Inc., a technology solutions firm, will acquire Beacon Roofing Supply, a leading roofing and exterior building product distributor, for approximately $11 billion. Brad Jacobs, chairman and CEO of QXO, stated, “Acquiring Beacon is a key milestone in our plan to create substantial shareholder value and establish QXO as a leader in the building-products distribution industry.”
This acquisition will enhance QXO’s market presence and operational capabilities in the building products sector, leveraging Beacon’s extensive distribution network and industry expertise.
James Hardie Buys The AZEK Company for $8.75 Billion
In March 2025, James Hardie Industries acquired The AZEK Company for approximately $8.75 billion. This strategic merger aims to create a leading platform in exterior and outdoor living building products by combining complementary product lines such as siding, exterior trim, decking, railing, and pergolas. James Hardie CEO Aaron Erter highlighted that the acquisition presents an opportunity to accelerate growth, enhance customer solutions, and deliver shareholder value.
Private Equity & Data-Driven Acquisitions
Clearlake Capital Buys Dun & Bradstreet
On March 24, 2025, Clearlake Capital Group will acquire Dun & Bradstreet Holdings, a leading global provider of business decisioning data and analytics, for $7.7 billion. The transaction is expected to close in the third quarter of 2025, subject to shareholder approval, regulatory clearances, and other customary closing conditions.
BC Partners Acquires GFL Environmental for $8 Billion
In January 2025, GFL Environmental, a Canadian diversified environmental services company, will sell its Environmental Services division to funds managed by Apollo Global Management and BC Partners affiliates for C$8 billion (approximately USD$5.6 billion). With sustainability in the spotlight, the acquisition adds a major waste management and environmental services company to its portfolio. This strategic move was intended to strengthen GFL’s financial position, providing greater flexibility to invest in organic growth initiatives and pursue mergers and acquisitions within its solid waste management segment.
Conclusion
Q1 2025 marked a strong rebound in global M&A activity across multiple sectors. Tech led the way with landmark deals driven by AI and cloud innovation. Energy and infrastructure deals reflected geopolitical and sustainability priorities. Healthcare focused on mental health and CNS advancements through strategic acquisitions. Companies pursued scale, synergy, and future-readiness through bold M&A moves. Checkout
Stay updated with the latest M&A deals driving the global industries with Intellizence.

Refreshed Daily